2024
Disparities in Receipt of Medications for Opioid Use Disorder Before and During the COVID-19 Pandemic in the US Veterans Health Administration.
Sung M, León C, Reisman J, Gordon K, Kerns R, Li W, Liu W, Mitra A, Yu H, Becker W. Disparities in Receipt of Medications for Opioid Use Disorder Before and During the COVID-19 Pandemic in the US Veterans Health Administration. Substance Use & Addiction Journal 2024, 29767342241293334. PMID: 39569566, DOI: 10.1177/29767342241293334.Peer-Reviewed Original ResearchMOUD receiptElixhauser Comorbidity IndexOpioid use disorderSocial determinants of healthVeterans Health Administration electronic health record dataElectronic health record dataUS Veterans Health AdministrationDeterminants of healthVeterans Health AdministrationHealth record dataProportion of veteransReceipt of medicationsSubstance useComorbidity indexTargeted outreach effortsUse disorderCOVID-19 pandemicProportion of patientsSocial determinantsReceipt of MOUDHealth AdministrationRecord dataEffect sizeMOUD engagementCalculated proportions
2010
Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain.
Starrels JL, Becker WC, Alford DP, Kapoor A, Williams AR, Turner BJ. Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain. Annals Of Internal Medicine 2010, 152: 712-20. PMID: 20513829, DOI: 10.7326/0003-4819-152-11-201006010-00004.Peer-Reviewed Original ResearchConceptsUrine drug testingOpioid treatment agreementsPrimary care settingOpioid misuseTreatment agreementsChronic painDrug testingEligible studiesCare settingsAberrant drug-related behaviorsDrug abuseMental Health Services AdministrationOpioid misuse outcomesChronic noncancer painCochrane Central RegisterProportion of patientsPrimary care studyControlled Clinical TrialsHealth Services AdministrationDrug-related behaviorsCombination of interventionsNoncancer painDiversity of interventionsOpioid medicationsCentral Register